Potassium Chloride Injection, Solution, Concentrate
Product Images NDC 63323-965

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 63323-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pot0s 0000 01

Pot0s 0000 01
Potassium Chloride injection solution concentrate at 2 meq/mL in a clear, colorless glass vial with a rubber stopper and metal cap. The vial label includes the product name, concentration, route of administration (intravenous), and the Fresenius Kabi USA, LLC labeler information.*
FDA Label Image

Pot0s 0000 02

Pot0s 0000 02
Potassium Chloride injection concentrate, USP, 10 mEq per 5 mL (2 mEq per mL) in a 5 mL single-dose vial. Label highlights the requirement that the concentrate must be diluted before intravenous administration. The product is preservative free and supplied by Fresenius Kabi USA, LLC. The label includes usage instructions, storage conditions, and a barcode.*
FDA Label Image

Pot0s 0000 03

Pot0s 0000 03
Potassium Chloride Injection Concentrate, USP, 2 mEq/mL, in single-dose vials of 5 mL, packaged as 25 vials. The label indicates the concentrate must be diluted before intravenous administration. It is preservative free, sterile, and nonpyrogenic, labeled by Fresenius Kabi USA, LLC.*
FDA Label Image

Pot0s 0000 04

Pot0s 0000 04
Potassium Chloride Injection Concentrate, USP in a 10 mL single-dose vial, labeled as 20 mEq per 10 mL (2 mEq per mL) intravenous solution concentrate. The label emphasizes that the concentrate must be diluted before use and is preservative free. It is labeled by Fresenius Kabi USA, LLC with a visible NDC 63323-965-03.*
FDA Label Image

Pot0s 0000 05

Pot0s 0000 05
Potassium Chloride Injection Concentrate USP, 2 mEq/mL, in 10 mL single dose vials, packaged 25 vials per container. Label warns that the concentrate must be diluted before use. The product is preservative free, sterile, nonpyrogenic, for intravenous administration, and labeled by Fresenius Kabi USA, LLC.*
FDA Label Image

Pot0s 0000 06

Pot0s 0000 06
Potassium Chloride Injection Concentrate USP 2 mEq/mL (40 mEq per 20 mL) in a single-dose vial. This preservative-free intravenous injectable solution is labeled with dilution instructions and storage information. The labeler is Fresenius Kabi USA, LLC, with NDC 63323-965-02.*
FDA Label Image

Pot0s 0000 07

Pot0s 0000 07
Potassium Chloride Injection Concentrate, USP 40 mEq per 20 mL (2 mEq per mL) in single-dose vials. The label highlights the requirement that the concentrate must be diluted prior to intravenous administration. It is preservative-free and manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. Additional details include sterility, nonpyrogenicity, and storage instructions at controlled room temperature.*
FDA Label Image

Pot0s 0000 08

Pot0s 0000 08
Potassium Chloride Injection Concentrate USP 2 mEq/mL in a 30 mL multiple-dose vial. Label clearly states "Concentrate Must Be Diluted Before Use" and details a total of 60 mEq per 30 mL. The product is sterile, nonpyrogenic, for intravenous administration, and labeled by Fresenius Kabi USA, LLC.*
FDA Label Image

Pot0s 0000 09

Pot0s 0000 09
Potassium Chloride Injection Concentrate, USP, 2 mEq/mL, by Fresenius Kabi USA, LLC. The label indicates a concentrate that must be diluted before use, with a total of 60 mEq per 30 mL vial. The package contains 25 multiple-dose vials of 30 mL each. It is for intravenous use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.